243 related articles for article (PubMed ID: 19853726)
1. [Comparative efficacy and acceptability of new-generation antidepressants. Synthesis meta-analysis Cipriani].
Gaillard R
Encephale; 2009 Oct; 35(5):499-504. PubMed ID: 19853726
[TBL] [Abstract][Full Text] [Related]
2. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
Favré P
Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.
Cipriani A; Furukawa TA; Salanti G; Geddes JR; Higgins JP; Churchill R; Watanabe N; Nakagawa A; Omori IM; McGuire H; Tansella M; Barbui C
Lancet; 2009 Feb; 373(9665):746-58. PubMed ID: 19185342
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI
J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis.
Furukawa TA; Salanti G; Atkinson LZ; Leucht S; Ruhe HG; Turner EH; Chaimani A; Ogawa Y; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Suganuma A; Watanabe N; Stockton S; Geddes JR; Cipriani A
BMJ Open; 2016 Jul; 6(7):e010919. PubMed ID: 27401359
[TBL] [Abstract][Full Text] [Related]
7. Which antidepressants have demonstrated superior efficacy? A review of the evidence.
Montgomery SA; Baldwin DS; Blier P; Fineberg NA; Kasper S; Lader M; Lam RW; Lépine JP; Möller HJ; Nutt DJ; Rouillon F; Schatzberg AF; Thase ME
Int Clin Psychopharmacol; 2007 Nov; 22(6):323-9. PubMed ID: 17917550
[TBL] [Abstract][Full Text] [Related]
8. Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Kishi T; Ikuta T; Sakuma K; Okuya M; Hatano M; Matsuda Y; Iwata N
Mol Psychiatry; 2023 Jan; 28(1):402-409. PubMed ID: 36253442
[TBL] [Abstract][Full Text] [Related]
9. Using meta-regression in performing indirect-comparisons: comparing escitalopram with venlafaxine XR.
Eckert L; Falissard B
Curr Med Res Opin; 2006 Nov; 22(11):2313-21. PubMed ID: 17076991
[TBL] [Abstract][Full Text] [Related]
10. [Severe forms of depression: the efficacy of escitalopram].
Spadone C
Encephale; 2009 Apr; 35(2):152-9. PubMed ID: 19393384
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of escitalopram and severity of depression: new data].
Spadone C
Encephale; 2009 Dec; 35(6):577-85. PubMed ID: 20004289
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
[TBL] [Abstract][Full Text] [Related]
13. Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?
Montgomery SA; Möller HJ
Int Clin Psychopharmacol; 2009 May; 24(3):111-8. PubMed ID: 19357527
[TBL] [Abstract][Full Text] [Related]
14. A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium.
Demyttenaere K; Hemels ME; Hudry J; Annemans L
Clin Ther; 2005 Jan; 27(1):111-24. PubMed ID: 15763612
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.
Boulenger JP; Huusom AK; Florea I; Baekdal T; Sarchiapone M
Curr Med Res Opin; 2006 Jul; 22(7):1331-41. PubMed ID: 16834832
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy, acceptability, and safety of medicinal, cognitive-behavioral therapy, and placebo treatments for acute major depressive disorder in children and adolescents: a multiple-treatments meta-analysis.
Ma D; Zhang Z; Zhang X; Li L
Curr Med Res Opin; 2014 Jun; 30(6):971-95. PubMed ID: 24188102
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy and acceptability of pharmacotherapeutic agents for anxiety disorders in children and adolescents: a mixed treatment comparison meta-analysis.
Uthman OA; Abdulmalik J
Curr Med Res Opin; 2010 Jan; 26(1):53-9. PubMed ID: 19905879
[TBL] [Abstract][Full Text] [Related]
18. Escitalopram therapy for major depression and anxiety disorders.
Baldwin DS; Reines EH; Guiton C; Weiller E
Ann Pharmacother; 2007 Oct; 41(10):1583-92. PubMed ID: 17848424
[TBL] [Abstract][Full Text] [Related]
19. Citalopram versus other anti-depressive agents for depression.
Cipriani A; Purgato M; Furukawa TA; Trespidi C; Imperadore G; Signoretti A; Churchill R; Watanabe N; Barbui C
Cochrane Database Syst Rev; 2012 Jul; 7(7):CD006534. PubMed ID: 22786497
[TBL] [Abstract][Full Text] [Related]
20. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
